News / Business
Simcere Pharmaceutical Group (SCR) to Hold Q4 2007 Earnings Conference Call March 4
Simcere
Pharmaceutical Group (NYSE:SCR) will hold a conference call on March 4 at
8:00 am to discuss the fourth quarter earnings for 2007.
Simcere Pharmaceutical manufactures and supplies branded
generic pharmaceuticals in the Chinese market.
The company focuses on introducing generic and pharmaceutical products
to treat diseases with high incidence and mortality rate.
Included in
the company’s product line is Bicun, a generic anti-stroke medication and Endu,
an anti-cancer medication also called Endostar.
The company
manufactures and sells 35 pharmaceutical products, such as antibiotics, an
anti-cancer medication and an anti-stroke medication. The company also distributes three pharmaceuticals
marketed, such as anti-inflammatory pain relievers, under its brand names.
Simcere
acquired Master Luck Corporation in November 2007.
For more
Conference Call related events or to post your own events, visit:
